Intermittent real-time continuous glucose monitoring for three months improved and sustained glycemic control better than self-monitoring in patients with type 2 diabetes who were not on prandial insulin treatment, researchers reported in Diabetes Care. Researchers noted a greater decline in hemoglobin A1C levels, without the need for intensified medications, in those who had RT-CGM compared with those in the self-monitoring group.

Related Summaries